Professional Documents
Culture Documents
Visceral Leishmaniasis
Nov. 13-15,2017
Bahir Dar
Leishmaniasis Control
Monitoring, Evaluation and
reporting system
NTD
Objectives
Improve understand on:
• Concept of M&E.
• Evaluation parameters in assessing VL/CL
interventions
• Importance of VL/CL control monitoring &
Evaluation systems.
Cont.-
• Key VL/Cl performance Indicators
• Sources of data and formats used to measure
VL/CL indicators
• Reporting Tools
• Common problems observed while VL/CL
reporting
Concept of M&E
What is Monitoring ?
A working Definition of monitoring
• ‘The systematic and continuous assessment of the
progress of a piece of work over time….It is a basic
and universal management tool for identifying the
strengths and weaknesses in a programme. Its
purpose is to help all the people involved make
appropriate and timely decisions that will improve
the quality of the work.’
NTD
Cont.
What is Evaluation ?
• Evaluation is defined as the systematic and
objective assessment of an on-going or
completed intervention, programme or policy, its
design, implementation and results.
• The aim is to determine Relevance and
Fulfilment of objectives, as well as Efficiency,
Effectiveness, Impact and Sustainability.
Cont. Evaluation
• An evaluation should provide information that is
credible and useful, enabling the incorporation
of lessons learned into the decision-making
process of both recipients and donors.
Important Evaluation parameters in assessing
VL/CL interventions :
The five basic evaluation parameters that are
important when assessing VL/CL intervention:
• Effectiveness;
• Efficiency;
• Relevance (Appropriateness);
• Impact;
• Coverage.
NTD
Cont.…
NTD
What are the strategies to meet the Objectives?
Delivery
Strategies Channels
• Increase access to early diagnosis and treatment; • Primary health
• Improve diagnostic and treatment skills; care unit),
• Conduct operational research on prevention of hospitals
Leshimaniasis
• Academia and
• Strengthen disease surveillance;
• Health education and promotion; research
• Vector Management (indoor residual spraying institutes
and Long Lasting Insecticide Treated Nets);
• Conduct clinical trial on treatment of CL and use
evidence to Increase treatment of severe CL cases
from 8 to 80 health facilities in endemic districts
by 2020.
What are the sources of data?
Registers, Logbooks & Disease record forms filled at
facilities and timely reported
- help us to measure VL/CL indicators
1. VL Registration book
2. Disease record form
3. Lab-logbook
NTD
VL Registration Form
Lab Result
A S Patient adderss (DAT/RDT/ Nutritonal
g e Travel Aspirate/Skin Nutritional treatement/m
S.N MRN Patient Full Name e x Zone District Kebele Village history Diagnosis scraping Status anagement
NTD
VL Registration form
3. Diagnosis and Laboratory Result :write the diagnosis and the diagnostic laboratory result as follows:
For the Diagnosis specify as: Primary KA,Relapse KA,PKDL, CL or MCL
For the lab-the diagnostic lab and the result as: DAT: as Pos, Neg, BL (for Positive, negative or borderline respectively)
Aspirte result with the parasitic load (as SA/BMA /LA +1, +2, +3, etc.)
RDT (Rapid Diagnostic Test, RK39): Pos or Neg.
Skin test result: Pos. or Neg.
4. Treatment : Specify drug and the dose in days given to the patient. E.g. SSG 30 - for a patient who has taken 30 days of SSG.
5. Travel history to KA endemic area : Specify it as: yes,no or Un known for travel to known Leishmaniases endemic areas.
NTD
Cont.…
6. Treatment outcome : Specify the treatment outcome as follows and and then write the date to the specified outcome in Ethiopian calendar as
day/mon/year: Disharged/cured,referral Defaulted,Relapse,Died or Failure and the date.
7. Conformation of Cure: clincal or parasitological
8. Serostatus : specify the HIV status of the patient as: Pos., Neg.or Unknow. If positive, is she/he on ART?
9. Date of admission/Discharge : write the date of admission/discharge of the patient in Ethiopian calendar
Pregnancy: if the patient is female, document her pregnancy status by 'Yes' or 'No' and state the trimester as 1st,2nd or 3rd. 'NA' if not applicable (in case of
male and children).
10. Other OI and its Rx : Specify the OI and write the treatment given for the specified Opportunistic Infection.
11. Complication or drug side effect: write the complication or side effect the patient developed due to Leishmania illness or the anti-Leishmania drug(s).
Reporting tools
NTD
Monthly VL Facility reporting Form
NTD
Cont.…
NTD
Cont.…
NTD
CL- Monthly Facility reporting
form
NTD
Cont.…
Cont.…
Common problems observed while
VL/CL reporting
Basic Requirements: Main problems:
NTD
Analysis of VL caseload based on
available performance data
NTD
Group Exercise
• Using 6 fictitious cases participant will practice
recording the patient’s history and treatment
status on the VL register book
• Based on the result of the exercise feedbacks will
be give by team
NTD